Replies to post #76081 on PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

Wrong! You can't show not one single targeted therapy having superior intellectual property to CiaB.

Janssen, nor anyone else for that matter would be interested in PharmaCyte's CiaB therapy if that was true.

[PINKribbon]

Wrong! It's not been 30 years. It's been a 20 year project that has since matured in it's technological development.

Now at it's current stage before the FDA!

[PINKribbon]

Wrong! The patents are relevant as explained to you in numerous previous posts.

Please, again, do your DD or go back and review those previous posts.